Cabergoline As An Adjuvant To Clomiphene Citrate For Management Of Unexplained Infertility

• Status: Unknown status
• Trial end date: 2019-11-01
• Target enrollment: 0
• Participant gender: Female

Summary

Infertility refers to an inability to conceive after having regular unprotected sex. Infertility can also refer to the biological inability of an individual to contribute to conception, or to a female who cannot carry a pregnancy to full term. In many countries infertility refers to a couple that has failed to conceive after 12 months of regular sexual intercourse

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Assiut University
• Treatments: Cabergoline; Citric Acid; Clomiphene; Enclomiphene; Zuclomiphene

Criteria

Inclusion Criteria:

• unexplained infertility, Primary or secondary.

• Absence of galactorrhoea.

• Normal serum prolactin.

• Normal hysterosalpingography.

• Normal spermogram.

Exclusion Criteria:

• Women on other line of treatment as aromatase inhibitors,gonadotrophins, or tamoxifen.

• Known hypersensitivity for cabergoline or clomiphene citrate.

• Other factors of infertility as tubal factor, uterine factor or male factor.